JPRN-UMIN000032164招募中未知
A study of biomarker predicting the effect of Nivolumab for unresectable advanced or recurrent gastric cancer. - Biomarker research of Nivolumab for gastic cancer.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous or metachronous (within 5 years) double cancers, except for intraepithelial tumor (Carcinoma in situ) or intramucosal tumor curatively resectable by local therapy at the time of Nivolumab treatment. 2) History of medical therapy for the purpose of the immune checkpoint inhibitors such as antiPD-1 antibody, antiPD-L1 antibody, antiCTLA-4 antibody or other T cell regulator before the Nivolumab treatment. 3) Having severe psychological illness and difficult to make a judgement for participation in the study. 4) Judged to be unfit to participate in the study by investigater.
研究者
相似试验
招募中
Unknown
Exploration of biomarkers to predict the effects of anti TSLP antibody (Tezepelumab) in refractory asthma patients using comprehensive analyses of changes in gene expression in whole blood cellsSevere asthmaJPRN-UMIN000050670Department of Respiratory Medicine, University of Tsukuba50
招募中
不适用
An exploratory investigation of the biomarker for senescence and arteriosclerosis in renal transplant donors and recipients.Recipients and donors in living-kidney transplantationJPRN-UMIN000004905Kagawa University, Faculty of Medicine45
已完成
不适用
A study of evaluation to the predictive biomarker of Nivolumab in peripheral blood and pleural effusion.previously treated patients with advanced non-small-cell lung cancerJPRN-UMIN000023873Respiratory Medicine, Allergy and Rheu matic Diseases Osaka University Graduate School of Medicine10
尚未招募
不适用
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CTAdvanced non small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesRPCEC00000392Center of Molecular Immunology130
尚未招募
Unknown
CIMAvaxEGF in Non Small Cell Lung Cancer. Exploratory Study of Biomarkerson-Small Cell Lung Cancer (NSCLC)RPCEC00000445Center of Molecular Immunology (CIM)20